Current role
Nicholas Grund
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Nicholas Grund
The proxy statement of Akebia Therapeutics, Inc. reports total compensation of $1,728,405 for Nicholas Grund in fiscal 2025, including a base salary of $506,742. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Akebia Therapeutics, Inc. (AKBA)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Akebia Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- John Butler CEO, CFO, Board Member
- John P. Butler CEO, Board Member
- Ellen Snow CFO
- Erik Ostrowski CFO
- Michel Dahan COO
- David A. Spellman Chief Accounting Officer
- Richard C. Malabre Chief Accounting Officer
- Adrian Adams Board Member
- LeAnne M. Zumwalt Board Member
- Michael Rogers Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Akebia Therapeutics, Inc. (AKBA) | Senior Vice President, Chief Commercial Officer | $506,742 | $1,728,405 |
| 2024 | Akebia Therapeutics, Inc. (AKBA) | Senior Vice President, Chief Commercial Officer | $459,393 | $1,854,631 |
Recent activity
No call appearances or filed executive changes recorded yet.